These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 27025077)

  • 1. [Tau imaging].
    Kudo Y; Furumoto S; Harada R; Okamura N
    Nihon Rinsho; 2016 Mar; 74(3):404-9. PubMed ID: 27025077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developments in Tau PET Imaging.
    Zimmer ER; Leuzy A; Gauthier S; Rosa-Neto P
    Can J Neurol Sci; 2014 Sep; 41(5):547-53. PubMed ID: 25424608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 18F-Labeled 2-Arylquinoline Derivatives for Tau Imaging: Chemical, Radiochemical, Biological and Clinical Features.
    Furumoto S; Tago T; Harada R; Kudo Y; Okamura N
    Curr Alzheimer Res; 2017; 14(2):178-185. PubMed ID: 27334944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of a PET tau tracer [(11)C]PBB3 for imaging of Alzheimer's disease.
    Wang M; Gao M; Xu Z; Zheng QH
    Bioorg Med Chem Lett; 2015 Oct; 25(20):4587-92. PubMed ID: 26323870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tau PET imaging in Alzheimer's disease.
    Okamura N; Harada R; Furumoto S; Arai H; Yanai K; Kudo Y
    Curr Neurol Neurosci Rep; 2014 Nov; 14(11):500. PubMed ID: 25239654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical Evaluation of [(18)F]THK-5105 Enantiomers: Effects of Chirality on Its Effectiveness as a Tau Imaging Radiotracer.
    Tago T; Furumoto S; Okamura N; Harada R; Adachi H; Ishikawa Y; Yanai K; Iwata R; Kudo Y
    Mol Imaging Biol; 2016 Apr; 18(2):258-66. PubMed ID: 26194011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different Positron Emission Tomography Tau Tracers Bind to Multiple Binding Sites on the Tau Fibril: Insight from Computational Modeling.
    Murugan NA; Nordberg A; Ågren H
    ACS Chem Neurosci; 2018 Jul; 9(7):1757-1767. PubMed ID: 29630333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of New Tau PET-Tracer Candidates With [18F]T808 and [18F]T807.
    Declercq L; Celen S; Lecina J; Ahamed M; Tousseyn T; Moechars D; Alcazar J; Ariza M; Fierens K; Bottelbergs A; Mariën J; Vandenberghe R; Andres IJ; Van Laere K; Verbruggen A; Bormans G
    Mol Imaging; 2016; 15():. PubMed ID: 27030397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concise and high-yield synthesis of T808 and T808P for radiosynthesis of [(18)F]-T808, a PET tau tracer for Alzheimer's disease.
    Gao M; Wang M; Zheng QH
    Bioorg Med Chem Lett; 2014 Jan; 24(1):254-7. PubMed ID: 24309505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acquisition of diagnostic tracers to enhance understanding of tau protein in Alzheimer's disease.
    Potticary J
    Bioanalysis; 2013 Jun; 5(12):1471-3. PubMed ID: 23795923
    [No Abstract]   [Full Text] [Related]  

  • 11. Relationship Between Tau and Cognition in the Evolution of Alzheimer's Disease: New Insights from Tau PET.
    Tanner JA; Rabinovici GD
    J Nucl Med; 2021 May; 62(5):612-613. PubMed ID: 33277390
    [No Abstract]   [Full Text] [Related]  

  • 12. The utility of the new research diagnostic criteria for Alzheimer's disease.
    Dubois B; Gauthier S; Cummings J
    Int Psychogeriatr; 2013 Feb; 25(2):175-7. PubMed ID: 23148941
    [No Abstract]   [Full Text] [Related]  

  • 13. A curcumin-based molecular probe for near-infrared fluorescence imaging of tau fibrils in Alzheimer's disease.
    Park KS; Seo Y; Kim MK; Kim K; Kim YK; Choo H; Chong Y
    Org Biomol Chem; 2015 Dec; 13(46):11194-9. PubMed ID: 26488450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Amyloid and tau imaging, its present and future].
    Okamura N; Harada R; Kudo Y; Yanai K
    Nihon Yakurigaku Zasshi; 2015 Sep; 146(3):144-9. PubMed ID: 26354014
    [No Abstract]   [Full Text] [Related]  

  • 15. Biomarkers: warning signs.
    Williams R
    Nature; 2011 Jul; 475(7355):S5-7. PubMed ID: 21760581
    [No Abstract]   [Full Text] [Related]  

  • 16. Structure-activity relationship around PI-2620 highlights the importance of the nitrogen atom position in the tricyclic core.
    Kroth H; Oden F; Serra AM; Molette J; Mueller A; Berndt M; Capotosti F; Gabellieri E; Schmitt-Willich H; Hickman D; Pfeifer A; Dinkelborg L; Stephens A
    Bioorg Med Chem; 2021 Dec; 52():116528. PubMed ID: 34839158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Research towards tau imaging.
    Jensen JR; Cisek K; Funk KE; Naphade S; Schafer KN; Kuret J
    J Alzheimers Dis; 2011; 26 Suppl 3():147-57. PubMed ID: 21971459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Brain imaging of Alzheimer' disease: state of the art and perspectives for clinicians].
    Trombella S; Assal F; Zekry D; Gold G; Giannakopoulos P; Garibotto V; Démonet JF; Frisoni GB
    Rev Med Suisse; 2016 Apr; 12(515):795-8. PubMed ID: 27276723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparisons of clinical symptoms in biomarker-confirmed Alzheimer's disease, dementia with Lewy bodies, and frontotemporal dementia patients in a local memory clinic.
    Shea YF; Ha J; Chu LW
    Psychogeriatrics; 2015 Dec; 15(4):235-41. PubMed ID: 25533477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pioneering Alzheimer's study in Colombia zeroes in on enigmatic protein.
    Reardon S
    Nature; 2018 Mar; 555(7698):567-568. PubMed ID: 29595782
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.